Catalyst Business Consulting (Catalyst BC) is announcing their client and partner, Jasper Development Group Inc. (JDG), has obtained a highly sought-after merit-based, limited license to process medical marijuana in Alabama from hundreds of applications. This achievement marks a significant milestone for both Alabama locals, Jasper Development Group Inc., and the rapidly evolving medical cannabis industry in the state.
Alabama’s recent legalization of medical marijuana has created opportunities for businesses looking to enter the emerging cannabis market. JDG, a pioneering entity committed to advancing patient care, has positioned itself at the forefront of this burgeoning industry in a notably conservative state.
Under the guidance of Catalyst BC, JDG undertook a rigorous merit application process, demonstrating their unwavering dedication to patient care, compliance, safety, quality, consistency, and innovation in providing medical marijuana in Alabama. A managed, comprehensive approach and commitment to excellence enabled JDG to secure one of the limited medical marijuana processor licenses issued by the AMCC on Monday, June 12th.
The medical marijuana processor license will allow JDG to produce a wide range of pharmaceutical-grade cannabis products including tinctures, topicals, lozenges, balms, salves, and more. These products will benefit Alabama medical patients with qualifying condition symptoms and improve their quality of life. While the state currently limits those who can obtain medical cannabis and the types of products available for treatment, Catalyst BC and JDG are hopeful that this first license will lead to more options for medical cannabis for Alabama residents.
“This is an incredibly proud moment for JDG,” said Tyler Robinson, CEO of JDG. “We are immensely grateful for the expert guidance and strategic support provided by Catalyst BC throughout this process. This license is a testament to our mission of helping our neighbors in Alabama with research and innovation in the medical marijuana industry.”
As part of its mission, JDG will build and operate a state-of-the-art medical cannabis processing facility, adhering to quality control measures to ensure the production of safe, reliable, and efficacious medical cannabis products. The company’s progressive vision will extend beyond its operations as it intends to collaborate with local healthcare providers, educational institutions, and other stakeholders to foster awareness and encourage further research into the therapeutic potential of medical cannabis in Alabama.
“We are honored to have been part of this journey with JDG’s internal team,” stated Ian Miller, CEO at Catalyst BC. “We are confident that JDG will contribute to Alabama’s medical cannabis landscape and the successful outcomes of its patients. This license award is a testament to the openness and will of Alabama’s voters and public servants and the dedication, professionalism, and vision of both JDG and Catalyst BC.”
